Testing effectiveness (Phase 2)UnknownNCT02422719What this trial is testingRadotinib as 3rd or Later Line Therapy in CP-CMLWho this might be right forChronic Myeloid Leukemia Ulsan University Hospital 73
Testing effectiveness (Phase 2)Looking for participantsNCT01746836What this trial is testingPonatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or NilotinibWho this might be right forChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive M.D. Anderson Cancer Center
Very early researchLooking for participantsNCT06398457What this trial is testingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesWho this might be right forHematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Study completedNCT00049192What this trial is testingOblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous LeukemiaRelapsing Chronic Myelogenous Leukemia National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT05143840What this trial is testingAsciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forChronic Myeloid Leukemia, Chronic PhaseAdult CMLLeukemia, Myeloid+1 more University of Alabama at Birmingham 100
Testing effectiveness (Phase 2)Study completedNCT00363649What this trial is testingInterferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKIWho this might be right forLeukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Not applicableEnded earlyNCT00594308What this trial is testingIn-Vivo Activated T-Cell Depletion to Prevent GVHDWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more Indiana University 10
Not applicableLooking for participantsNCT06724536What this trial is testingInteraction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CMLWho this might be right forLeukemia,Myeloid, Chronic Carmen Fava 100
Not applicableStudy completedNCT00478985What this trial is testingEvaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid LeukemiaWho this might be right forMyeloid Leukemia, Chronic University Hospital, Bordeaux 100
Early research (Phase 1)Study completedNCT00422825What this trial is testingEffect of Food on Bioavailability of a Modified Release Formulation of ImatinibWho this might be right forHealthy Novartis Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00129740What this trial is testingPhase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)Who this might be right forLeukemia, Myelogenous, Chronic M.D. Anderson Cancer Center 148
Testing effectiveness (Phase 2)Study completedNCT00118326What this trial is testingDonor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseWho this might be right forKidney CancerLeukemiaLymphoma+3 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT01511289What this trial is testingRadotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase PatientsWho this might be right forLeukemiaLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL Positive+3 more Il-Yang Pharm. Co., Ltd. 242
Testing effectiveness (Phase 2)Study completedNCT00072579What this trial is testingSargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial TreatmentWho this might be right forLeukemia Wake Forest University Health Sciences
Large-scale testing (Phase 3)UnknownNCT00025402What this trial is testingChemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia III. Medizinische Klinik Mannheim 1,000
Testing effectiveness (Phase 2)Study completedNCT00739141What this trial is testingConditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.Who this might be right forLeukemiaMyelodysplastic SyndromeNon-Hodgkins Lymphoma+2 more Memorial Sloan Kettering Cancer Center 86
Large-scale testing (Phase 3)UnknownNCT00002869What this trial is testingInterferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous LeukemiaWho this might be right forLeukemia Medical Research Council 800
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Not applicableActive Not RecruitingNCT06092879What this trial is testingAsciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in FranceWho this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 201
Large-scale testing (Phase 3)Study completedNCT00514488What this trial is testingImatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)Who this might be right forChronic Myeloid Leukemia University of Bologna